Once-Weekly Epoetin Beta Is Highly Effective in Treating Anaemic Patients With Lymphoproliferative Malignancy and Defective Endogenous Erythropoietin Production

British Journal of Haematology - United Kingdom
doi 10.1111/j.1365-2141.2004.04886.x
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2004English

Treating Renal Anaemia With Erythropoietin

BMJ
1990English

Comparison of the Therapeutic Efficacy of Epoetin Beta and Epoetin Alfa in Maintenance Phase Hemodialysis Patients

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2011English

Endogenous Erythropoietin, Acute Kidney Injury, and Prognosis in Patients With Acute Coronary Syndrome

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2019English

Liraglutide Is Effective in Type 2 Diabetic Patients With Sustained Endogenous Insulin-Secreting Capacity

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2011English

New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide

Bone Research
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2014English

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy